Invention Grant
- Patent Title: Compounds which selectively modulate the CB2 receptor
- Patent Title (中): 选择性调节CB2受体的化合物
-
Application No.: US13627149Application Date: 2012-09-26
-
Publication No.: US08735430B2Publication Date: 2014-05-27
- Inventor: Alessandra Bartolozzi , Eugene Richard Hickey , Doris Riether , Lifen Wu , Renee M. Zindell , Nigel James Blumire , Monika Ermann , Edward Thomas Glenn , Someina Khor , Przemyslaw Zawadzki
- Applicant: Alessandra Bartolozzi , Eugene Richard Hickey , Doris Riether , Lifen Wu , Renee M. Zindell , Nigel James Blumire , Monika Ermann , Edward Thomas Glenn , Someina Khor , Przemyslaw Zawadzki
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Anthony P. Bottino
- Main IPC: C07D261/14
- IPC: C07D261/14 ; C07D413/12 ; C07D413/14 ; C07D417/06 ; C07D417/12 ; C07D417/14
Abstract:
Compounds of formula (I) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.
Public/Granted literature
- US20130030022A1 Compounds Which Selectively Modulate The CB2 Receptor Public/Granted day:2013-01-31
Information query
